Robert J. Jones, MBChB, PhD | Authors

Articles

COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

May 15, 2018

Abiraterone has become the first-choice treatment for men with metastatic prostate cancer.